Battle of the Superbugs: How the Pharmaceutical Industry can Combat Antimicrobial Resistance

The development of antimicrobial resistance (AMR) and the increase of superbugs can be linked to the discharge of pharmaceuticals into the environment (PiE). Global pharmaceutical companies and their supply chains are facing increasing pressure from consumers, investors, and regulators to act.